Evidence map›Paper›PMID 20877914›Full record

ArticleMolecular bioSystems2010

A multi-pronged search for a common structural motif in the secretion signal of Salmonella enterica serovar Typhimurium type III effector proteins.

Garry W Buchko, George Niemann, Erin S Baker, Mikhail E Belov, Richard D Smith, Fred Heffron, Joshua N Adkins, Jason E McDermott

Abstract read
In one paragraph

Article in Molecular bioSystems, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Systematic Identification of Intracellular-Translocated Candidate Effectors inFrontiers in cellular and infection microbiology · 2018
    Article
  11. The TAL Effector AvrBs3 fromFrontiers in microbiology · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Garry W BuchkoFundamental and Computational Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352, USA. garry.buchko@pnl.gov
George Niemann
Erin S Baker
Mikhail E Belov
Richard D Smith
Fred Heffron
Joshua N Adkins
Jason E McDermott

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2003 to 2011
$25.1M
SALMONELLA GENES REQUIRED FOR SURVIVAL IN THE MACROPHAGER01AI022933 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI HEFFRON, FRED L · 1987 to 2013
$4.6M
SURFACE CHEMISTRY OF MYCOBACTERIAR01AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1989 to 1989
–
SURFACE CHEMISTRY OF MYCOBACTERIAR22AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1985 to 1989
–
NCI NIH HHS R21 CA12619-01NCRR NIH HHS P41 RR018522NCRR NIH HHS RR 18522NIAID NIH HHS R01 AI022933NIAID NIH HHS Y01 AI008401NIAID NIH HHS Y1-AI-8401-01
6 · The paper itself

Abstract

Many pathogenic Gram-negative bacteria use a type III secretion system (T3SS) to deliver effector proteins into the host cell where they reprogram host defenses and facilitate pathogenesis. The first 20-30 N-terminal residues usually contain the 'secretion signal' that targets effector proteins for translocation, however, a consensus sequence motif has never been discerned. Recent machine-learning approaches, such as support vector machine (SVM)-based Identification and Evaluation of Virulence Effectors (SIEVE), have improved the ability to identify effector proteins from genomics sequence information. While these methods all suggest that the T3SS secretion signal has a characteristic amino acid composition bias, it is still unclear if the amino acid pattern is important and if there are any unifying structural properties that direct recognition. To address these issues a peptide corresponding to the secretion signal for Salmonella enterica serovar Typhimurium effector SseJ was synthesized (residues 1-30, SseJ) along with scrambled peptides of the same amino acid composition that produced high (SseJ-H) and low (SseJ-L) SIEVE scores. The secretion properties of these three peptides were tested using a secretion signal-CyaA fusion assay and their structural properties probed using circular dichroism, nuclear magnetic resonance, and ion mobility spectrometry-mass spectrometry. The secretion predictions from SIEVE matched signal-CyaA fusion experimental results with J774 macrophages suggesting that the SseJ secretion signal has some sequence order dependence. The structural studies showed that the SseJ, SseJ-H, and SseJ-L peptides were intrinsically disordered in aqueous solution with a small predisposition to adopt nascent helical structure only in the presence of structure stabilizing agents such as 1,1,1,3,3,3-hexafluoroisopropanol. Intrinsic disorder may be a universal feature of effector secretion signals as similar conclusions were reached following structural characterization of peptides corresponding to the N-terminal regions of the S. Typhimurium effectors SptP, SopD-2, GtgE, and the Yersinia pestis effector YopH.

Indexed as

Protein Sorting SignalsAdenylate Cyclase ToxinAlgorithmsAmino Acid MotifsAmino AcidsAmino Acid SequenceBacterial ProteinsBiological AssayCircular DichroismComputational BiologyCyclic AMPHydrocarbons, FluorinatedMagnetic Resonance SpectroscopyMass SpectrometryMolecular Sequence DataPeptidesAdenylate Cyclase ToxinAmino AcidsBacterial ProteinsCyclic AMPhexafluoroisopropanolHydrocarbons, FluorinatedPeptidesPropanolsProtein Sorting SignalsTrifluoroethanol

Identifiers

PMID20877914
PMCPMC3282560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.